Skip to main navigation Skip to search Skip to main content

Major Adverse Cognitive Events (MACE-Cog): A New “MACE” Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke

  • Aravind Ganesh*
  • , Sajeevan Sujanthan
  • , Ryan T. Muir
  • , Raed A. Joundi
  • , Michael D. Hill
  • , Terence J. Quinn
  • , Bijoy Menon
  • , Tolulope Sajobi
  • , Jennifer S. Rabin
  • , Katie N. Dainty
  • , Morgan D. Barense
  • , Krista L. Lanctôt
  • , James Kennedy
  • , Rajesh K. Kharbanda
  • , Douglas S. Lee
  • , Mario F.L. Gaudio
  • , Stephen Fremes
  • , Ruth M. Masterson Creber
  • , Eric E. Smith
  • , Richard H. Swartz*
  • *Corresponding author for this work
  • University of Calgary
  • Institute of Medical Sciences
  • University of Toronto
  • Hamilton Health Sciences
  • University of Glasgow
  • Rehabilitation Sciences Institute
  • Harquail Centre for Neuromodulation
  • North York General Hospital
  • Departments of Psychiatry and Pharmacology and Toxicology
  • Geriatric Psychopharmacology Research Group
  • University of Oxford
  • NIHR Oxford Biomedical Research Centre
  • Oxford University Hospitals NHS Foundation Trust
  • John Radcliffe Hospital
  • Peter Munk Cardiac Centre
  • Institute for Clinical Evaluative Sciences
  • Cornell University
  • Division of Cardiac Surgery
  • Columbia University

Research output: Contribution to journalReview articlepeer-review

Abstract

Cardiovascular diseases, particularly stroke, are leading causes of dementia. Several common cardiac interventions such as coronary artery bypass grafting and transcatheter aortic valve implantation are also associated with cognitive decline. However, cognitive outcomes continue to be poorly collected in clinical trials of cardiovascular diseases. In this article, we review the limitations of current approaches to cognitive assessment in cardiovascular disease studies. When assessed, there is wide variation in cognitive tasks used, and tasks have limited population-specific validation, are subject to floor and ceiling effects, and may suffer from sociocultural and linguistic biases. Many tasks are not available in multilingual formats and often rely on face-to-face testing with trained coordinators. All conventional cognitive outcomes in cardiovascular trials are associated with substantial incompletion, especially among older and more impaired individuals, the very people most important to capture. This nonrandom missingness generates survivor and attrition biases, an unacceptable situation for any trial outcome. Last, the meaning of measured cognitive outcomes is often unclear for patients, caregivers, clinicians, and regulators. To help address these limitations, we propose a new framework, major adverse cognitive events (MACE-Cog), to better capture cognitive outcomes in stroke and other cardiovascular populations. As an inclusive construct reflecting the multidimensional nature of cognitive decline, major adverse cognitive events do not rely solely on performance on cognitive testing but also consider inability to complete cognitive testing due to cognitive-behavioral factors, reported symptoms of cognitive decline, impairment in activities of daily living as a result of cognitive impairment, new clinical diagnoses of dementia, and care home admission. We hope that the proposed composite outcome and multiple use cases presented spark progress in cardiovascular research toward more inclusive approaches to the study of cognitive outcomes that move beyond the confines of cognitive tests alone.

Original languageEnglish
Pages (from-to)378-394
Number of pages17
JournalCirculation
Volume154
Issue number4
DOIs
StatePublished - Jul 2026
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cardiovascular diseases
  • cognition
  • randomized controlled trial
  • stroke

Fingerprint

Dive into the research topics of 'Major Adverse Cognitive Events (MACE-Cog): A New “MACE” Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke'. Together they form a unique fingerprint.

Cite this